117 related articles for article (PubMed ID: 7107368)
1. Pharmacokinetic studies using multiple administration of RO 03-8799, a 2-nitroimidazole radiosensitizer.
Stratford MR; Minchinton AI; Hill SA; McNally NJ; Williams MV
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):469-71. PubMed ID: 7107368
[TBL] [Abstract][Full Text] [Related]
2. In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administration.
Williams MV; Denekamp J; Minchinton AI; Stratford MR
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):477-81. PubMed ID: 7107370
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
4. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
Stratford MR; Minchinton AI; Dische S; Saunders MI; Anderson P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):377-9. PubMed ID: 7107355
[TBL] [Abstract][Full Text] [Related]
5. A comparison of tumor and normal tissue levels of acidic, basic and neutral 2-nitroimidazole radiosensitizers in mice.
Minchinton AI; Stratford MR
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1117-20. PubMed ID: 2943710
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
White R; Workman P; Owen L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
10. The reversible N-oxidation of the nitroimidazole radiosensitizer Ro 03-8799.
Walton MI; Bleehen NM; Workman P
Biochem Pharmacol; 1985 Nov; 34(21):3939-40. PubMed ID: 4062968
[No Abstract] [Full Text] [Related]
11. Bromomisonidazole: synthesis and characterization of a new radiosensitizer.
Rasey JS; Krohn KA; Freauff S
Radiat Res; 1982 Sep; 91(3):542-54. PubMed ID: 7122830
[No Abstract] [Full Text] [Related]
12. A phase I study of the hypoxic cell radiosensitizer Ro-03-8799.
Roberts JT; Bleehen NM; Workman P; Walton MI
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1755-8. PubMed ID: 6480458
[TBL] [Abstract][Full Text] [Related]
13. The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations.
Saunders MI; Anderson PJ; Bennett MH; Dische S; Minchinton A; Stratford MR; Tothill M
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1759-63. PubMed ID: 6480459
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration.
Hill SA; Fowler JF; Minchinton AI; Stratford MR; Denekamp J
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Aug; 44(2):143-50. PubMed ID: 6603435
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
[TBL] [Abstract][Full Text] [Related]
16. The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.
Saunders MI; Dische S; Fermont D; Bishop A; Lenox-Smith I; Allen JG; Malcolm SL
Br J Cancer; 1982 Nov; 46(5):706-10. PubMed ID: 7171452
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake of misonidazole and analogues with acidic or basic functions.
Dennis MF; Stratford MR; Wardman P; Watts ME
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
Eifel PJ; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans.
Allen JG; Dische S; Lenox-Smith I; Malcolm SL; Saunders MI
Eur J Clin Pharmacol; 1984; 27(4):483-9. PubMed ID: 6519157
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
